TrialClinical pharmacology in drug development2021

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.

Julie Desrivot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.